Skip to main content

Remote Job Finders (RJF)

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie and Eli Lilly strike mid-sized deals in obesity and molecular glues, priority review vouchers set to take a hit and immuno-oncology matures.
Tariff Threat Continues, More Meetings Cancelled, AbbVie Makes Obesity Play, More
Scroll to top